Safety and Efficacy of OCL 503 in Prostate Artery Embolization

Clinical trial NCT02509975 · COMPLETED

Trial details

NCT number: NCT02509975
Sponsor: IMBiotechnologies Ltd.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia Benign Prostatic Hypertrophy

Start date: 2015-09-01
Primary completion: 2018-05-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.